EGFR and neoplasm: 35d alone or with TKIs suppressed tumor growth in TKI-resistant LUAD tumors, including those with variant resistant mechanisms such as a common factor, nuclear PKCδ (found in >40% of the resistant LUADs) (12), and EGFR C797S mutation (found in ∼15% of the resistant LUADs) (7).